Cargando…

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Alzheimer’s Disease

Despite a wealth of knowledge gained in the past three decades concerning the molecular underpinnings of Alzheimer’s disease (AD), progress towards obtaining effective, disease modifying therapies has proven to be challenging. In this manner, numerous clinical trials targeting the production, aggreg...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohn, Troy T, Kim, Nayoung, Isho, Noail F, Mack, Jacob M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078432/
https://www.ncbi.nlm.nih.gov/pubmed/30090689
http://dx.doi.org/10.4172/2161-0460.1000439